<

Selling “Pink Viagra”

 

NYT Business article about the efforts to make and market a female sex pill.

Regulators and doctors tend to be less tolerant of side effects in quality-of-life drugs than they are in medicines intended to mitigate life-and-death diseases. Some industry critics, meanwhile, contend that in the quest to find new and treatable quality-of-life problems, drug makers are not so much identifying unmet needs as they are stoking existing social anxieties to weld to their medicines.

Tags:

Posted by Will Baum, LCSW